aspirin has been researched along with Cholelithiasis in 23 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Data from 4524 patients in a randomized, controlled trial of aspirin were analyzed to determine if aspirin reduced the risk for hospitalization for gallstone disease." | 9.07 | One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease. ( Abbey, D; Kurata, JH; Marks, J, 1991) |
| "The effect of aspirin on cholesterol cholelithiasis was examined in the hamster and the prairie dog." | 7.68 | Aspirin does not inhibit cholesterol cholelithiasis in two established animal models. ( Ayyad, N; Cohen, BI; McSherry, CK; Mosbach, EH; Yoshii, M, 1991) |
| "Patients with gallstone disease have impaired gallbladder motility." | 6.68 | Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules. ( Baijal, SS; Das, A; Saraswat, VA, 1995) |
| "Data from 4524 patients in a randomized, controlled trial of aspirin were analyzed to determine if aspirin reduced the risk for hospitalization for gallstone disease." | 5.07 | One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease. ( Abbey, D; Kurata, JH; Marks, J, 1991) |
| " All patients were contacted for ultrasonography and were interviewed for additional information on daily intake of aspirin, NSAIDs, cholesterol lowering medication, estrogen therapy, and biliary pain during follow-up." | 3.70 | Gallstone recurrence after successful shock wave therapy: the magnitude of the problem and the predictive factors. ( Afschrift, M; Cesmeli, E; De Buyzere, M; Elewaut, A; Elewaut, AE; Kerre, T, 1999) |
| "The effect of aspirin on cholesterol cholelithiasis was examined in the hamster and the prairie dog." | 3.68 | Aspirin does not inhibit cholesterol cholelithiasis in two established animal models. ( Ayyad, N; Cohen, BI; McSherry, CK; Mosbach, EH; Yoshii, M, 1991) |
| "Patients with gallstone disease have impaired gallbladder motility." | 2.68 | Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules. ( Baijal, SS; Das, A; Saraswat, VA, 1995) |
| "In the aspirin group the recurrence rate was 18." | 2.67 | Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy? ( Adamek, HE; Buttmann, A; Riemann, JF; Weber, J, 1994) |
| "Treatment with aspirin led to a significant reduction in mucus biosynthesis by the gall bladder mucosa." | 2.67 | Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy. ( Allen, A; Dowling, RH; Lennard, TW; Murphy, G; Rhodes, M, 1992) |
| "With aspirin, there was no change in deoxycholate but a decrease in arachidonate and no change in glycoprotein." | 2.67 | Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight. ( Bonorris, GG; Marks, JW; Schoenfield, LJ, 1991) |
| "In the United States, pancreatic cancer is the 4(th) leading cause of cancer death, and in Europe it is the 6th." | 2.42 | Epidemiology of pancreatic cancer. ( Michaud, DS, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (34.78) | 18.7374 |
| 1990's | 14 (60.87) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michaud, DS | 1 |
| Smith, BF | 1 |
| LaMont, JT | 2 |
| Kupfer, RM | 1 |
| Northfield, TC | 1 |
| Lee, SP | 1 |
| Carey, MC | 1 |
| Das, A | 1 |
| Baijal, SS | 1 |
| Saraswat, VA | 1 |
| Borch, K | 1 |
| Chu, M | 1 |
| Kullman, E | 1 |
| Carlsson, B | 1 |
| Rehfeld, JF | 1 |
| Adamek, HE | 1 |
| Buttmann, A | 1 |
| Weber, J | 1 |
| Riemann, JF | 1 |
| Kam, DM | 1 |
| Webb, PA | 1 |
| Sandman, G | 1 |
| Chugh, A | 1 |
| Vertz, ML | 1 |
| Scheeres, DE | 1 |
| Sahlin, S | 1 |
| MacPherson, BR | 1 |
| Pemsingh, RS | 1 |
| Sterling, RK | 1 |
| Shiffman, ML | 1 |
| Cesmeli, E | 1 |
| Elewaut, AE | 1 |
| Kerre, T | 1 |
| De Buyzere, M | 1 |
| Afschrift, M | 1 |
| Elewaut, A | 1 |
| Méndez-Sánchez, N | 1 |
| Lizardi-Cervera, J | 1 |
| Morán, S | 1 |
| Uribe, M | 1 |
| Rhodes, M | 1 |
| Allen, A | 1 |
| Dowling, RH | 2 |
| Murphy, G | 1 |
| Lennard, TW | 1 |
| Cohen, BI | 1 |
| Mosbach, EH | 1 |
| Ayyad, N | 1 |
| Yoshii, M | 1 |
| McSherry, CK | 1 |
| Kurata, JH | 1 |
| Marks, J | 1 |
| Abbey, D | 1 |
| Marks, JW | 2 |
| Bonorris, GG | 2 |
| Schoenfield, LJ | 2 |
| Xu, Z | 1 |
| Hood, K | 1 |
| Gleeson, D | 1 |
| Ruppin, DC | 1 |
| Broomfield, PH | 1 |
| Chopra, R | 1 |
| Sheinbaum, RC | 1 |
| Silverman, A | 1 |
| Besançon, F | 2 |
| Marche, C | 2 |
| Barret, C | 1 |
| Parrot, J | 1 |
1 review available for aspirin and Cholelithiasis
| Article | Year |
|---|---|
Epidemiology of pancreatic cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholecystectomy; Cholelithiasis; Chronic Disease; | 2004 |
8 trials available for aspirin and Cholelithiasis
| Article | Year |
|---|---|
Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid.
Topics: Aged; Aspirin; Bile; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Female; Gallbladder; Humans | 1983 |
Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules.
Topics: Adult; Aspirin; Cholelithiasis; Double-Blind Method; Drug Administration Schedule; Female; Gallbladd | 1995 |
Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy?
Topics: Adult; Aged; Aspirin; Cholelithiasis; Female; Follow-Up Studies; Humans; Life Tables; Lithotripsy; M | 1994 |
Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Bile; Cholelithiasis; Cholesterol; Depression, Chemical; Fe | 1992 |
One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease.
Topics: Adult; Aged; Aspirin; Cholelithiasis; Double-Blind Method; Female; Hospitalization; Humans; Male; Mi | 1991 |
Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight.
Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Cholelithiasis; Cholesterol; Deoxycholic Acid; Dinopro | 1991 |
Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholelithiasis; Dr | 1988 |
Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
Topics: Adult; Aspirin; Bile; Cholelithiasis; Cholesterol; Crystallization; Deoxycholic Acid; Double-Blind M | 1988 |
14 other studies available for aspirin and Cholelithiasis
| Article | Year |
|---|---|
The pathogenesis of gallstones.
Topics: Animals; Aspirin; Bile; Bile Acids and Salts; Cholelithiasis; Cholesterol; Cricetinae; Crystallizati | 1984 |
Aspirin prevention of cholesterol gallstone formation in prairie dogs.
Topics: Animals; Aspirin; Bile; Cholelithiasis; Cholesterol, Dietary; Crystallization; Culture Techniques; G | 1981 |
Endogenous hypercholecystokininemia, but not aspirin, reduces the gallstone incidence in the hamster model.
Topics: Animals; Aspirin; Biliopancreatic Diversion; Cholecystokinin; Cholelithiasis; Cricetinae; Diet; Male | 1994 |
A novel 5-lipoxygenase inhibitor prevents gallstone formation in a lithogenic prairie dog model.
Topics: Animals; Aspirin; Cholelithiasis; Cholesterol; Cyclooxygenase Inhibitors; Disease Models, Animal; En | 1996 |
Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Topics: Aspirin; Bile; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Female; Humans; Lipids; Male; Mid | 1996 |
Ground squirrel model for cholelithiasis: role of epithelial glycoproteins.
Topics: Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile; Calcium; Cholelithiasi | 1997 |
Nonsteroidal antiinflammatory drugs and gallstone disease: will an aspirin a day keep the gallstones away?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholagogues and Choleretics; Cholelithiasis; Chole | 1998 |
Gallstone recurrence after successful shock wave therapy: the magnitude of the problem and the predictive factors.
Topics: Actuarial Analysis; Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Aci | 1999 |
Cholesterol gallstones and aspirin.
Topics: Animals; Aspirin; Cholelithiasis; Cholesterol; Cricetinae; Disease Models, Animal; Dogs; Male; Mesoc | 1992 |
Aspirin does not inhibit cholesterol cholelithiasis in two established animal models.
Topics: Animals; Aspirin; Bile; Bile Acids and Salts; Cholelithiasis; Cholesterol; Cholesterol, Dietary; Cri | 1991 |
[Changes in bile components during the formation and prevention of black pigment gallstone in a guinea pig model].
Topics: Animals; Aspirin; Bile; Bile Acids and Salts; Bilirubin; Calcium; Cholelithiasis; Glycoproteins; Gui | 1990 |
The treatment of pulmonary embolism.
Topics: Adult; Aspirin; Blood Coagulation Tests; Cholelithiasis; Diabetes Complications; Female; Heparin; Hu | 1973 |
[Pathologic and therapeutic similarities between arteriosclerosis and lithiasic cholecystitis].
Topics: Acetamides; Aminosalicylic Acids; Animals; Arteriosclerosis; Aspirin; Cholecystitis; Cholelithiasis; | 1971 |
[Experimental therapy of gallbladder lithiasis. Preventive and curative effects of various drugs in mice].
Topics: Animals; Aspirin; Cholelithiasis; Cholestyramine Resin; Clofibrate; Dehydrocholic Acid; Hydantoins; | 1970 |